Skip to main content
. 2022 Jan 30;9:20499361211073248. doi: 10.1177/20499361211073248

Table 4.

Clinical Outcomes.

IV (n = 146) PO (n = 98) p value
LOS, days, median (IQR) 10 (5–21) 5 (4–6) <0.01
30-day recurrence, n (%) 3 (2.1) 1 (1.0) 0.65
30-day readmission, n (%) 29 (19.9) 15 (15.3) 0.40
30-day all-cause mortality, n (%) 6 (4.1) 1 (1.0) 0.25
Adverse reactions, n (%) 2 (1.4) 3 (3.1) 0.39

IQR, interquartile range; IV, intravenous; LOS, length of stay; PO, oral.